AIM:To evaluate the safety and efficacy of human embryonic stem cells(h ESCs)for the management of type 2 diabetes mellitus(T2DM).METHODS:Patients with a previous history of diabetes and its associated complications w...AIM:To evaluate the safety and efficacy of human embryonic stem cells(h ESCs)for the management of type 2 diabetes mellitus(T2DM).METHODS:Patients with a previous history of diabetes and its associated complications were enrolled and injected with hE SC lines as per the defined protocol.The patients were assessed using Nutech functional score(NFS),a numeric scoring scale to evaluate the patients for 11 diagnostic parameters.Patients were evaluated at baseline and at the end of treatment period 1(T1).All the parameters were graded on the NFS scale from 1to 5.Highest possible grade(HPG)of 5 was considered as the grade of best improvement.RESULTS:Overall,94.8%of the patients showed improvement by at least one grade of NFS at the end of T1.For all the 11 parameters evaluated,54%of patients achieved HPG after treatment.The four essential parameters(improvement in glycated hemoglobin(HbA 1c)and insulin level,and fall in number of other oral hypoglycemic drugs with and without insulin)are presented in detail.For Hb A1c,72.6%of patients at the end of T1 met the World Health Organization cut off value,i.e.,6.5%of HbA 1c.For insulin level,65.9%of patients at the end of T1 were able to achieve HPG.After treatment,the improvement was seen in 16.3%of patients who required no more than two medications along with insulin.Similarly,21.5%of patients were improved as their dosage regimen for using oral drugs was reduced to 1-2 from 5.CONCLUSION:hE SC therapy is beneficial in patients with diabetes and helps in reducing their dependence on insulin and other medicines.展开更多
Background: Low vision is referred to as visual impairment (VI) if it is not cured through surgery, drugs, spectacles or contact lenses. It interferes with day-to-day living activities and is associated with the major...Background: Low vision is referred to as visual impairment (VI) if it is not cured through surgery, drugs, spectacles or contact lenses. It interferes with day-to-day living activities and is associated with the major eye blinding diseases. Numerous tests are used to carry out diagnosis of VI, but their outcomes are unreliable. Objective: To develop a functional scoring system, for accessing the ailment of patients with VI based on observations and clinical symptoms. Methods and Findings: We prepared the list of all possible symptoms that were associated with low vision. Based on this list, we established a scoring system, Nutech Functional Score (NFS), which is a 33-point positional and directional scoring system that evaluates the patient with VI. The scores have been converted into numeric values for conducting probability based studies. All the symptoms are graded between 1 to 5 that runs in BAD → GOOD direction. Conclusion: NFS is a distinctive tool that can be used globally to evaluate the patients with low vision.展开更多
AIM To describe the morphogenesis of different neuronal cells from the human embryonic stem cell(h ESC) line,SCT-N,under in vitro culture conditions.METHODS The directed neuronal cell line was produced from a single,s...AIM To describe the morphogenesis of different neuronal cells from the human embryonic stem cell(h ESC) line,SCT-N,under in vitro culture conditions.METHODS The directed neuronal cell line was produced from a single,spare,pre-implantation stage fertilized ovum that was obtained during a natural in vitro fertilization process. The h ESCs were cultured and maintained as per our proprietary in-house technology in a Good Manufacturing Practice,Good Laboratory Practice and Good Tissue Practice compliant laboratory. The cell line was derived and incubated in aerobic conditions. The cells were examined daily under a phase contrast microscope for their growth and differentiation. RESULTS Different neural progenitor cells(NPCs) and differentiating neurons were observed under the culture conditions. Multipotent NPCs differentiated into all three types of nervous system cells,i.e.,neurons,oligodendrocytes and astrocytes. Small projections resembling neurites or dendrites,and protrusion coming out of the cells,were observed. Differentiating cells were observed at day 18 to 20. The differentiating neurons,neuronal bodies,axons,and neuronal tissue were observed on day 21 and day 30 of the culture. On day 25 and day 30,prominent neurons,axons and neuronal tissue were observed under phase contrast microscopy. 4',6-diamidino-2-phenylindole staining also indicated the pattern of differentiating neurons,axonal structure and neuronal tissue. CONCLUSION This study describes the generation of different neuronal cells from an h ESC line derived from biopsy of blastomeres at the two-cell cleavage stage from a discarded embryo.展开更多
Background: Diabetes mellitus (DM) is a metabolic disorder characterized by hyperglycemia. The symptoms of hyperglycemia include polyuria, polydypsia, polyphagia, blurred vision and weight loss. Various diagnostic tes...Background: Diabetes mellitus (DM) is a metabolic disorder characterized by hyperglycemia. The symptoms of hyperglycemia include polyuria, polydypsia, polyphagia, blurred vision and weight loss. Various diagnostic tests are used for the diagnosis of DM in patients, but the findings of these tests cannot be assumed to be completely valid. This study aimed at developing a novel scoring system to assess the patients suffering from DM. Method: We assessed the patients based on various diagnostic tests available for DM and prepared a single list of these tests. The tests were categorized and graded based on the World Health Organization (WHO) criteria. Further, we coverted the grades into numeric values for easy use. Results: NFS for diabetes is an 11-point scoring system that assesses the patient’s condition before and after therapy. To facilitate the conduct of probability based studies, we have converted the scores into numeric values in the range of (0, 1). Each symptom is graded as (1, 2, 3, 4, 5) that runs in BAD → GOOD direction. Conclusion: NFS is a beneficial scoring system that can be used worldwide to assess the patients with DM.展开更多
AIM To develop a new scoring system, nutech functional scores(NFS) for assessing the patients with spinal cord injury(SCI).METHODS The conventional scale, American Spinal Injury Association's(ASIA) impairment scal...AIM To develop a new scoring system, nutech functional scores(NFS) for assessing the patients with spinal cord injury(SCI).METHODS The conventional scale, American Spinal Injury Association's(ASIA) impairment scale is a measure which precisely describes the severity of the SCI.However, it has various limitations which lead to incomplete assessment of SCI patients.We have developed a 63 point scoring system, i.e., NFS for patients suffering with SCI.A list of symptoms either common or rare that were found to be associated with SCI was recorded for each patient.On the basis of these lists, we have developed NFS.RESULTS These lists served as a base to prepare NFS, a 63 point positional(each symptom is sub-graded and get points based on position) and directional(moves in direction BAD → GOOD) scoring system.For non-progressive diseases, 1, 2, 3, 4, 5 denote worst, bad, moderate, good and best(normal), respectively.NFS for SCI has been divided into different groups based on the affected part of the body being assessed, i.e., motor assessment(shoulders, elbow, wrist, fingers-grasp, fingers-release, hip, knee, ankle and toe), sensory assessment, autonomic assessment, bed sore assessment and general assessment.As probability based studies required a range of(-1, 1) or at least the range of(0, 1) to be useful for real world analysis, the grades were converted to respective numeric values.CONCLUSION NFS can be considered as a unique tool to assess the improvement in patients with SCI as it overcomes the limitations of ASIA impairment scale.展开更多
Introduction: Diabetes mellitus (DM), a metabolic disorder, is known to be highly prevalent in people aged 40 - 60 years in developing countries whereas in developed countries, it mostly affects people above the age o...Introduction: Diabetes mellitus (DM), a metabolic disorder, is known to be highly prevalent in people aged 40 - 60 years in developing countries whereas in developed countries, it mostly affects people above the age of 60 years. It is of two types: DM type I, an autoimmune disorder that mostly onsets after an infection and DM type II that is commonly associated with obesity. Several treatments are available for the treatment of DM, but none has successfully cured diabetes. Nowadays, stem cell therapy is being investigated for use in the treatment of DM and has shown positive results. Case Report: Our study presented results of three diabetic patients who were treated with human embryonic stem cell (hESC) therapy. Following the therapy, blood glucose levels were reduced. An improvement was observed in eye sight, stamina, gait pattern endurance, mental focus ability and muscle strength. There was a reduction in secondary side effects of high blood sugar such as affectation of cardiac, kidneys, polyneuropathy, vision etc. No adverse events and teratoma formation were observed after the treatment. Conclusion: It was concluded that hESCs showed good therapeutic potential in the treatment of patients with diabetes.展开更多
文摘AIM:To evaluate the safety and efficacy of human embryonic stem cells(h ESCs)for the management of type 2 diabetes mellitus(T2DM).METHODS:Patients with a previous history of diabetes and its associated complications were enrolled and injected with hE SC lines as per the defined protocol.The patients were assessed using Nutech functional score(NFS),a numeric scoring scale to evaluate the patients for 11 diagnostic parameters.Patients were evaluated at baseline and at the end of treatment period 1(T1).All the parameters were graded on the NFS scale from 1to 5.Highest possible grade(HPG)of 5 was considered as the grade of best improvement.RESULTS:Overall,94.8%of the patients showed improvement by at least one grade of NFS at the end of T1.For all the 11 parameters evaluated,54%of patients achieved HPG after treatment.The four essential parameters(improvement in glycated hemoglobin(HbA 1c)and insulin level,and fall in number of other oral hypoglycemic drugs with and without insulin)are presented in detail.For Hb A1c,72.6%of patients at the end of T1 met the World Health Organization cut off value,i.e.,6.5%of HbA 1c.For insulin level,65.9%of patients at the end of T1 were able to achieve HPG.After treatment,the improvement was seen in 16.3%of patients who required no more than two medications along with insulin.Similarly,21.5%of patients were improved as their dosage regimen for using oral drugs was reduced to 1-2 from 5.CONCLUSION:hE SC therapy is beneficial in patients with diabetes and helps in reducing their dependence on insulin and other medicines.
文摘Background: Low vision is referred to as visual impairment (VI) if it is not cured through surgery, drugs, spectacles or contact lenses. It interferes with day-to-day living activities and is associated with the major eye blinding diseases. Numerous tests are used to carry out diagnosis of VI, but their outcomes are unreliable. Objective: To develop a functional scoring system, for accessing the ailment of patients with VI based on observations and clinical symptoms. Methods and Findings: We prepared the list of all possible symptoms that were associated with low vision. Based on this list, we established a scoring system, Nutech Functional Score (NFS), which is a 33-point positional and directional scoring system that evaluates the patient with VI. The scores have been converted into numeric values for conducting probability based studies. All the symptoms are graded between 1 to 5 that runs in BAD → GOOD direction. Conclusion: NFS is a distinctive tool that can be used globally to evaluate the patients with low vision.
文摘AIM To describe the morphogenesis of different neuronal cells from the human embryonic stem cell(h ESC) line,SCT-N,under in vitro culture conditions.METHODS The directed neuronal cell line was produced from a single,spare,pre-implantation stage fertilized ovum that was obtained during a natural in vitro fertilization process. The h ESCs were cultured and maintained as per our proprietary in-house technology in a Good Manufacturing Practice,Good Laboratory Practice and Good Tissue Practice compliant laboratory. The cell line was derived and incubated in aerobic conditions. The cells were examined daily under a phase contrast microscope for their growth and differentiation. RESULTS Different neural progenitor cells(NPCs) and differentiating neurons were observed under the culture conditions. Multipotent NPCs differentiated into all three types of nervous system cells,i.e.,neurons,oligodendrocytes and astrocytes. Small projections resembling neurites or dendrites,and protrusion coming out of the cells,were observed. Differentiating cells were observed at day 18 to 20. The differentiating neurons,neuronal bodies,axons,and neuronal tissue were observed on day 21 and day 30 of the culture. On day 25 and day 30,prominent neurons,axons and neuronal tissue were observed under phase contrast microscopy. 4',6-diamidino-2-phenylindole staining also indicated the pattern of differentiating neurons,axonal structure and neuronal tissue. CONCLUSION This study describes the generation of different neuronal cells from an h ESC line derived from biopsy of blastomeres at the two-cell cleavage stage from a discarded embryo.
文摘Background: Diabetes mellitus (DM) is a metabolic disorder characterized by hyperglycemia. The symptoms of hyperglycemia include polyuria, polydypsia, polyphagia, blurred vision and weight loss. Various diagnostic tests are used for the diagnosis of DM in patients, but the findings of these tests cannot be assumed to be completely valid. This study aimed at developing a novel scoring system to assess the patients suffering from DM. Method: We assessed the patients based on various diagnostic tests available for DM and prepared a single list of these tests. The tests were categorized and graded based on the World Health Organization (WHO) criteria. Further, we coverted the grades into numeric values for easy use. Results: NFS for diabetes is an 11-point scoring system that assesses the patient’s condition before and after therapy. To facilitate the conduct of probability based studies, we have converted the scores into numeric values in the range of (0, 1). Each symptom is graded as (1, 2, 3, 4, 5) that runs in BAD → GOOD direction. Conclusion: NFS is a beneficial scoring system that can be used worldwide to assess the patients with DM.
文摘AIM To develop a new scoring system, nutech functional scores(NFS) for assessing the patients with spinal cord injury(SCI).METHODS The conventional scale, American Spinal Injury Association's(ASIA) impairment scale is a measure which precisely describes the severity of the SCI.However, it has various limitations which lead to incomplete assessment of SCI patients.We have developed a 63 point scoring system, i.e., NFS for patients suffering with SCI.A list of symptoms either common or rare that were found to be associated with SCI was recorded for each patient.On the basis of these lists, we have developed NFS.RESULTS These lists served as a base to prepare NFS, a 63 point positional(each symptom is sub-graded and get points based on position) and directional(moves in direction BAD → GOOD) scoring system.For non-progressive diseases, 1, 2, 3, 4, 5 denote worst, bad, moderate, good and best(normal), respectively.NFS for SCI has been divided into different groups based on the affected part of the body being assessed, i.e., motor assessment(shoulders, elbow, wrist, fingers-grasp, fingers-release, hip, knee, ankle and toe), sensory assessment, autonomic assessment, bed sore assessment and general assessment.As probability based studies required a range of(-1, 1) or at least the range of(0, 1) to be useful for real world analysis, the grades were converted to respective numeric values.CONCLUSION NFS can be considered as a unique tool to assess the improvement in patients with SCI as it overcomes the limitations of ASIA impairment scale.
文摘Introduction: Diabetes mellitus (DM), a metabolic disorder, is known to be highly prevalent in people aged 40 - 60 years in developing countries whereas in developed countries, it mostly affects people above the age of 60 years. It is of two types: DM type I, an autoimmune disorder that mostly onsets after an infection and DM type II that is commonly associated with obesity. Several treatments are available for the treatment of DM, but none has successfully cured diabetes. Nowadays, stem cell therapy is being investigated for use in the treatment of DM and has shown positive results. Case Report: Our study presented results of three diabetic patients who were treated with human embryonic stem cell (hESC) therapy. Following the therapy, blood glucose levels were reduced. An improvement was observed in eye sight, stamina, gait pattern endurance, mental focus ability and muscle strength. There was a reduction in secondary side effects of high blood sugar such as affectation of cardiac, kidneys, polyneuropathy, vision etc. No adverse events and teratoma formation were observed after the treatment. Conclusion: It was concluded that hESCs showed good therapeutic potential in the treatment of patients with diabetes.
